Drug
Who makes pemigatinib?
2 companies list pemigatinib as a human prescription drug, including under the names PEMAZYRE. Forms: tablet. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing pemigatinib
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Incyte Corporation | tablet | NDANDA213736 | 3 | 0 |
| Lonza Tampa LLC | tablet | DRUG FOR FURTHER PROCESSING | 3 | 0 |
Bulk ingredient listings
- CARBOGEN AMCIS AGSwitzerland · 1 NDC
- MSN Laboratories Private Limited,India · 1 NDC
Orange Book patents
5 unexpired patents list pemigatinib as the active ingredient, expiring between Apr 2034 and Oct 2040. Application holder: INCYTE CORP.
Enquiry
Common questions
- Who makes pemigatinib?
- 2 companies list pemigatinib as a human prescription drug in the openFDA NDC Directory, led by Incyte Corporation, Lonza Tampa LLC. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies pemigatinib active ingredient?
- 2 companies list pemigatinib as a bulk ingredient, including CARBOGEN AMCIS AG, MSN Laboratories Private Limited,.